Haegarda C1 inhibitors 3000 units.
Ended Awarded
- Contract number
- 36C24824F0327
- Awardee
-
CSL Behring L.L.C. UEI H3WKVE9VBLY3
- Awarding agency
-
Veterans Integrated Service Network 8
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $391,583
Award facts
- Contract value 100% obligated
- $391,582.80 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- King of Prussia, PA 19406, USA
Award details come from SAM.gov/FPDS.
About this award
This is a federal contract award by the U.S. Department of Veterans Affairs (VA) to CSL Behring L.L.C., a global biotherapeutics company. The contract, valued at $391,582.80, is for the delivery of HAEGARDA, a C1 inhibitor treatment for hereditary angioedema, to VA medical facilities.
The contract is a Delivery Order placed under CSL Behring's Federal Supply Schedule (FSS) contract with the VA, contract number 36F79721D0249, under the Pharmaceuticals and Drugs schedule (FSS-61-IB). This is an indefinite delivery vehicle that allows the VA to efficiently procure CSL Behring's pharmaceutical products through task orders and Blanket Purchase Agreements. The contract does not have a set-aside designation.
The contract has a period of performance ending on September 30, 2024. This award is one of multiple contracts and BPAs the VA has in place with CSL Behring to ensure a reliable supply of critical treatments for veterans across the VA healthcare system.
Quick answers
Who was awarded contract 36C24824F0327?
36C24824F0327 was awarded to CSL Behring L.L.C. by Veterans Integrated Service Network 8 (Veterans Health Administration) on September 6, 2024.
How much is contract 36C24824F0327 worth?
The government has obligated $391,583 on 36C24824F0327.
Is contract 36C24824F0327 an order under another contract?
Yes. 36C24824F0327 is a delivery order under 36F79721D0249, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 36C24824F0327 competed?
The extent of competition for 36C24824F0327 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award